Anzeige
Mehr »
Samstag, 07.02.2026 - Börsentäglich über 12.000 News
Der Shakeout: Silber hat genau das getan, was echte Bullenmärkte immer tun - es hat die Touristen abgeschüttelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Seeking Alpha

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrCVS pharmacies accepting TrumpRx discount cards
FrMGM China Holdings Non-GAAP EPS of $1.60, revenue of $4.6B
FrVenzee Technologies names Hebe Chen as CFO
FrTMX Group GAAP EPS of $0.60, revenue of $457.8M
FrGoldmoney reports Q3 results
FrVerde Clean Fuels to suspend development of Permian Basin project
FrRyder declares $0.91 dividend
FrMid Penn Bancorp, 1st Colonial Bancorp receive regulatory approvals for merger
FrGencor GAAP EPS of $0.23, revenue of $23.57M
FrWhite Mountains Insurance GAAP EPS of $327.23, revenue of $1.60M
FrWestinghouse Air Brake declares $0.31 dividend
FrAcadia Realty Trust announces key promotions and changes to management team
FrBoise Cascade declares $0.22 dividend
FrBimergen Energy expects NYSE American uplisting, plans concurrent offering
FrFed's Daly leans towards more rate cuts amid job market vulnerabilities - report
FrTech Voices: Huang on AI CapEx, Goldman-Anthropic, China CPU delays
FrVeeco approves merger with Axcelis
FrAmerican Drive Acquisition to begin separate trading of shares and warrants
FrTotec Resources lists shares on Frankfurt Stock Exchange
FrRegency outlines 3.25%-3.75% same-property NOI growth target while advancing $1B development pipeline
FrU.S. drilling rig count keeps climbing in Baker Hughes survey
FrThe Coca-Cola Company climbs for the seventh straight session
FrPlains All American outlines $2.75B EBITDA guidance for 2026 as company executes NGL divestiture, streamlining, and Cactus III integration
FrDow smashes 50,000 and here's how all 30 stocks rank according to SA Quant Ratings
FrRoivant signals multiple pivotal trial readouts and accelerates brepocitinib Phase III launch in 2026